Targeted covalent
inhibitors are an important class of drugs and
chemical probes. However, relatively few electrophiles meet the criteria
for successful covalent inhibitor design. Here we describe α-substituted
methacrylamides as a new class of electrophiles suitable for targeted
covalent inhibitors. While typically α-substitutions inactivate
acrylamides, we show that hetero α-substituted methacrylamides
have higher thiol reactivity and undergo a conjugated addition–elimination
reaction ultimately releasing the substituent. Their reactivity toward
thiols is tunable and correlates with the p
K
a
/p
K
b
of the leaving group. In
the context of the BTK inhibitor ibrutinib, these electrophiles showed
lower intrinsic thiol reactivity than the unsubstituted ibrutinib
acrylamide. This translated to comparable potency in protein labeling,
in vitro kinase assays, and functional cellular assays, with improved
selectivity. The conjugate addition–elimination reaction upon
covalent binding to their target cysteine allows functionalizing α-substituted
methacrylamides as turn-on probes. To demonstrate this, we prepared
covalent ligand directed release (CoLDR) turn-on fluorescent probes
for BTK, EGFR, and K-Ras
G12C
. We further demonstrate a
BTK CoLDR chemiluminescent probe that enabled a high-throughput screen
for BTK inhibitors. Altogether we show that α-substituted methacrylamides
represent a new and versatile addition to the toolbox of targeted
covalent inhibitor design.